Management of Significant Bradycardia Detected During Home Sleep Testing
Initial Assessment and Evaluation
- The American Heart Association recommends determining if the bradycardia is clinically significant by assessing if the heart rate is typically <50 beats per minute and inappropriate for the clinical condition 2, 3
- The American College of Cardiology suggests screening for symptoms of sleep apnea syndrome with subsequent confirmatory testing directed by clinical suspicion 1
- Evaluate for signs of increased work of breathing and check oxyhemoglobin saturation in patients with suspected sleep apnea 2
- Assess for symptoms potentially related to bradycardia such as syncope, presyncope, or altered mental status 2, 4
Diagnostic Approach
- Consider Holter monitor (24-72 hours) for frequent symptoms, external loop recorder or patch recorder (2-14 days) for symptoms likely to recur within 2-6 weeks, and mobile cardiac outpatient telemetry (up to 30 days) for infrequent symptoms 5
- Implantable cardiac monitor may be considered for very infrequent symptoms (>30 days between episodes) 5, 6
- Perform laboratory tests such as thyroid function tests, electrolytes, and pH to rule out reversible causes 6
Treatment Algorithm
- The American Heart Association recommends initiating treatment directed specifically at sleep apnea (e.g., continuous positive airway pressure and weight loss) for sleep-related bradycardia with documented obstructive sleep apnea 1
- For symptomatic bradycardia requiring immediate treatment, maintain patent airway, assist breathing as necessary, and provide supplementary oxygen if hypoxemic 2, 3
- Consider atropine 0.5 mg IV every 3-5 minutes to a maximum total dose of 3 mg for symptomatic bradycardia 2
Follow-up Recommendations
- Ensure adherence to CPAP therapy and follow up to confirm resolution of bradycardia in patients with sleep-related bradycardia and documented obstructive sleep apnea 1
- Monitor for improvement in symptoms and cardiac rhythm after initiating appropriate treatment 1